Results 201 to 210 of about 10,064 (258)

The rise of AI in healthcare education: DeepSeek and GPT-4o take on the 2024 Taiwan Pharmacist Exam. [PDF]

J Chin Med Assoc
Wang YM, Chen TJ.
europepmc   +1 more source

Bioequivalence centres in Africa: current state and opportunities for growth. [PDF]

J Pharm Policy Pract
Ncube BM, Muthuri S, Ajose O, Kikwai L.
europepmc   +1 more source

Integrating In Vitro BE Checker with In Silico Physiologically Based Biopharmaceutics Modeling to Predict the Pharmacokinetic Profiles of Oral Drug Products. [PDF]

Pharmaceutics
Niino T, Masada T, Takagi T, Kataoka M, Yoshida H, Yamashita S, Kambayashi A.   +6 more
europepmc   +1 more source

Explainable AI in Pharmaceutics: Grad-CAM Analysis of Surface Dissolution Imaging Using Convolutional Neural Networks. [PDF]

Pharmaceutics
Al-Baghdadi A, Pacławski A, Szlęk J, Mendyk A.   +3 more
europepmc   +1 more source

Impact of Mild Traumatic Brain Injury (mTBI) on CYP2D6 Activity and the Restorative Effects of Melatonin and Vitamin C Supplementation. [PDF]

Iran J Pharm Res
Berenjian K, Gholipour Z, Khoshayand M, Sharifzadeh M, Rouini M, Hosseinzadeh Ardakani Y.   +5 more
europepmc   +1 more source

Effect of <i>Helicobacter pylori</i> infection on the risk of inflammatory bowel disease: an umbrella review and second-order meta-analysis. [PDF]

Ther Adv Gastroenterol
Wang X, Zhao H, Yu H, Liu J, Zhang Y, Chen J, Qi X.   +6 more
europepmc   +1 more source

Classification of WHO Essential Oral Medicines for Children Applying a Provisional Pediatric Biopharmaceutics Classification System

Pharmaceutics, 2019
The objective was using the Essential Medicines List for children by the World Health Organization (WHO) to create a pediatric biopharmaceutics classification system (pBCS) of the oral drugs included in the Essential Medicines List by the World Health ...
Isabel Gonzalez-Alvarez, Marta Gonzalez-Alvarez, Andres Navarro   +2 more
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Theranostic of biopharmaceuticals

Pharmacology & Therapeutics, 2017
Monoclonal antibodies (mAbs) and fusion proteins with an Fc portion of immunoglobulin G (IgG) are emblematic of the remarkable expansion of biopharmaceuticals. Despite their biological origin, these products display an interindividual variability in their efficacy and/or side effects, which must be taken into consideration.
Benjamin, Chaigne, Hervé, Watier
openaire   +2 more sources

Pharmacovigilance of Biopharmaceuticals

Drug Safety, 2009
Biopharmaceuticals are important treatment options for a variety of chronic and sometimes life-threatening diseases. Compared with the traditional small molecule drugs, biopharmaceuticals have specific characteristics, which might also influence their safety profile.
Giezen, Thijs J, Mantel-Teeuwisse, Aukje K, Leufkens, Hubert G M   +2 more
openaire   +3 more sources